Hope, Michael J.
Acuitas Therapeutics (Canada)
21 papers on CoChat
Most cited papers
- Verified
Rational design of cationic lipids for siRNA delivery
Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology
RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery
Cited by 1,822
- Verified
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
Akinc, A., Maier, M. A., Manoharan, M., Fitzgerald, K., Jayaraman, M., Barros, S., Ansell, S., Du, X., Hope, M. J., Madden, T. D., et al. (2019) · Nature Nanotechnology
RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery
Cited by 1,636
- Verified
Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo
Jayaraman, M., Ansell, S. M., Mui, B. L., Tam, Y. K., Chen, J., Du, X., Butler, D., Eltepu, L., Matsuda, S., Narayanannair, J. K., et al. (2012) · Angewandte Chemie International Edition
RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery
Cited by 1,267
- Verified
Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms
Akinc, A., Querbes, W., De, S., Qin, J., Frank-Kamenetsky, M., Jayaprakash, K. N., Jayaraman, M., Rajeev, K. G., Cantley, W. L., Dorkin, J. R., et al. (2010) · Molecular Therapy
RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery
Cited by 1,261
- Verified
Lipid Nanoparticle Systems for Enabling Gene Therapies
Cullis, P. R., & Hope, M. J. (2017) · Molecular Therapy
RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery
Cited by 1,208
- Verified
Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes
Pardi, N., Tuyishime, S., Muramatsu, H., Kariko, K., Mui, B. L., Tam, Y. K., Madden, T. D., Hope, M. J., & Weissman, D. (2015) · Journal of Controlled Release
RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery
Cited by 1,014
- Verified
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
Pardi, N., Hogan, M. J., Pelc, R. S., Muramatsu, H., Andersen, H., DeMaso, C. R., Dowd, K. A., Sutherland, L. L., Scearce, R. M., Parks, R., et al. (2017) · Nature
Mosquito-borne diseases and controlRNA Interference and Gene Delivery
Cited by 884
- Verified
Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics
Maier, M. A., Jayaraman, M., Matsuda, S., Liu, J., Barros, S., Querbes, W., Tam, Y. K., Ansell, S. M., Kumar, V., Qin, J., et al. (2013) · Molecular Therapy
RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery
Cited by 625
- Verified
Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses
Pardi, N., Hogan, M. J., Naradikian, M. S., Parkhouse, K., Cain, D. W., Jones, L., Moody, M. A., Verkerke, H. P., Myles, A., Willis, E., et al. (2018) · Journal of Experimental Medicine
Immunotherapy and Immune ResponsesRNA Interference and Gene Delivery
Cited by 530
- Verified
Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals
Thess, A., Grund, S., Mui, B. L., Hope, M. J., Baumhof, P., Fotin-Mleczek, M., & Schlake, T. (2015) · Molecular Therapy
RNA Interference and Gene DeliveryRNA and protein synthesis mechanisms
Cited by 513
- Verified
Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures
Semple, S. C., Klimuk, S. K., Harasym, T. O., Dos Santos, N., Ansell, S. M., Wong, K. F., Maurer, N., Stark, H., Cullis, P. R., Hope, M. J., et al. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes
RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery
Cited by 454
- Verified
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
Pardi, N., Secreto, A. J., Shan, X., Debonera, F., Glover, J., Yi, Y., Muramatsu, H., Ni, H., Mui, B. L., Tam, Y. K., et al. (2017) · Nature Communications
RNA Interference and Gene DeliveryMonoclonal and Polyclonal Antibodies Research
Cited by 352
- Verified
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
Pardi, N., Parkhouse, K., Kirkpatrick, E., McMahon, M., Zost, S. J., Mui, B. L., Tam, Y. K., Karikó, K., Barbosa, C. J., Madden, T. D., et al. (2018) · Nature Communications
Influenza Virus Research StudiesSARS-CoV-2 and COVID-19 Research
Cited by 281
- Verified
Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines
Lutz, J., Lazzaro, S., Habbeddine, M., Schmidt, K. E., Baumhof, P., Mui, B. L., Tam, Y. K., Madden, T. D., Hope, M. J., Heidenreich, R., et al. (2017) · npj Vaccines
RNA Interference and Gene DeliveryImmunotherapy and Immune Responses
Cited by 257
- Verified
PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake
Parhiz, H., Shuvaev, V. V., Pardi, N., Khoshnejad, M., Kiseleva, R. Y., Brenner, J. S., Uhler, T., Tuyishime, S., Mui, B. L., Tam, Y. K., et al. (2018) · Journal of Controlled Release
RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery
Cited by 233
- Verified
mRNA mediates passive vaccination against infectious agents, toxins, and tumors
Thran, M., Mukherjee, J., Pönisch, M., Fiedler, K., Thess, A., Mui, B. L., Hope, M. J., Tam, Y. K., Horscroft, N., Heidenreich, R., et al. (2017) · EMBO Molecular Medicine
RNA Interference and Gene DeliveryImmunotherapy and Immune Responses
Cited by 166
- Verified
Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**
Jayaraman, M., Ansell, S. M., Mui, B. L., Tam, Y. K., Chen, J., Du, X., Butler, D., Eltepu, L., Matsuda, S., Narayanannair, J. K., et al. (2012) · Angewandte Chemie
RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery
Cited by 150
- Verified
Intracellular Delivery and Antibacterial Activity of Gentamicin Encapsulated in pH-Sensitive Liposomes
Lutwyche, P., Cordeiro, C., Wiseman, D. J., St-Louis, M., Uh, M., Hope, M. J., Webb, M. S., & Finlay, B. B. (1998) · Antimicrobial Agents and Chemotherapy
Nanoparticle-Based Drug DeliveryRNA Interference and Gene Delivery
Cited by 121
- Verified
Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques
Pardi, N., LaBranche, C. C., Ferrari, G., Cain, D. W., Tombácz, I., Parks, R. J., Muramatsu, H., Mui, B. L., Tam, Y. K., Karikó, K., et al. (2019) · Molecular Therapy - Nucleic Acids
HIV Research and TreatmentSARS-CoV-2 and COVID-19 Research
Cited by 103
- Verified
Enhancing siRNA delivery by employing lipid nanoparticles
Hope, M. J. (2014) · Therapeutic Delivery
RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery
Cited by 22
- Verified
Pieter Cullis’ quest for a lipid-based, fusogenic delivery system for nucleic acid therapeutics: success with siRNA so what about mRNA?
Tam, Y. K., Madden, T. D., & Hope, M. J. (2016) · Journal of Drug Targeting
RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery
Cited by 20
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free